Latest period
$3.92B
YoY change
-23.3%
5Y CAGR
+9.9%
Peak year (2024)
$21.47B
Latest annual
$16.47B
Operating Cash Flow history chart for Merck & Co. (MRK) from 1989 to 2025
Latest: $16.47B
Operating Cash Flow growth chart for Merck & Co. (MRK) from 1989 to 2025
Latest: -23.3%
Operating Cash Flow history table for Merck & Co. (MRK) from 1989 to 2025
| 2025 | $16.47B | -23.3% | −$5.00B | ||
| 2024 | $21.47B | +65.1% | +$8.46B | ||
| 2023 | $13.01B | -31.9% | −$6.09B | ||
| 2022 | $19.09B | +35.3% | +$4.99B | ||
| 2021 | $14.11B | +37.6% | +$3.86B | ||
| 2020 | $10.25B | -23.7% | −$3.19B | ||
| 2019 | $13.44B | +23.1% | +$2.52B | ||
| 2018 | $10.92B | +69.4% | +$4.47B | ||
| 2017 | $6.45B | -37.9% | −$3.93B | ||
| 2016 | $10.38B | -16.5% | −$2.04B | ||
| 2015 | $12.42B | +58.0% | +$4.56B | ||
| 2014 | $7.86B | -32.6% | −$3.79B | ||
| 2013 | $11.65B | +16.3% | +$1.63B | ||
| 2012 | $10.02B | -19.1% | −$2.36B | ||
| 2011 | $12.38B | +14.4% | +$1.56B | ||
| 2010 | $10.82B | +219.0% | +$7.43B | ||
| 2009 | $3.39B | -48.4% | −$3.18B | ||
| 2008 | $6.57B | -6.1% | −$427.50M | ||
| 2007 | $7.00B | +3.5% | +$234.00M | ||
| 2006 | $6.77B | -11.1% | −$843.30M | ||
| 2005 | $7.61B | -13.5% | −$1.19B | ||
| 2004 | $8.80B | -10.8% | −$1.06B | ||
| 2003 | $9.86B | +3.5% | +$333.70M | ||
| 2002 | $9.53B | +4.9% | +$448.80M | ||
| 2001 | $9.08B | +18.1% | +$1.39B | ||
| 2000 | $7.69B | +25.4% | +$1.56B | ||
| 1999 | $6.13B | +15.1% | +$802.40M | ||
| 1998 | $5.33B | -15.6% | −$988.30M | ||
| 1997 | $6.32B | +16.4% | +$888.90M | ||
| 1996 | $5.43B | +84.4% | +$2.48B | ||
| 1995 | $2.94B | -28.9% | −$1.20B | ||
| 1994 | $4.14B | +35.8% | +$1.09B | ||
| 1993 | $3.05B | +21.7% | +$544.10M | ||
| 1992 | $2.50B | +2.9% | +$70.40M | ||
| 1991 | $2.43B | +18.4% | +$378.40M | ||
| 1990 | $2.06B | +48.9% | +$674.90M | ||
| 1989 | $1.38B | — | — |
- 2025$16.47B-23.3%
- 2024$21.47B+65.1%
- 2023$13.01B-31.9%
- 2022$19.09B+35.3%
- 2021$14.11B+37.6%
- 2020$10.25B-23.7%
- 2019$13.44B+23.1%
- 2018$10.92B+69.4%
- 2017$6.45B-37.9%
- 2016$10.38B-16.5%
- 2015$12.42B+58.0%
- 2014$7.86B-32.6%
- 2013$11.65B+16.3%
- 2012$10.02B-19.1%
- 2011$12.38B+14.4%
- 2010$10.82B+219.0%
- 2009$3.39B-48.4%
- 2008$6.57B-6.1%
- 2007$7.00B+3.5%
- 2006$6.77B-11.1%
- 2005$7.61B-13.5%
- 2004$8.80B-10.8%
- 2003$9.86B+3.5%
- 2002$9.53B+4.9%
- 2001$9.08B+18.1%
- 2000$7.69B+25.4%
- 1999$6.13B+15.1%
- 1998$5.33B-15.6%
- 1997$6.32B+16.4%
- 1996$5.43B+84.4%
- 1995$2.94B-28.9%
- 1994$4.14B+35.8%
- 1993$3.05B+21.7%
- 1992$2.50B+2.9%
- 1991$2.43B+18.4%
- 1990$2.06B+48.9%
- 1989$1.38B—
Operating Cash Flow values are taken from Merck & Co.'s reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Operating Cash Flow at Merck & Co. (MRK)
Operating Cash Flow for Merck & Co. (MRK): headline value $3.92B · YoY -23.3%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Merck & Co. (MRK) operating cash flow is $16.47B – declined 23.3% year-over-year.
Through 2020–2025 (5 years), Merck & Co. operating cash flow delivered a +9.9% annualised rate; with mixed annual results across the window.
Between 2024 and 2025, Merck & Co. operating cash flow declined 23.3%, falling from $21.47B to $16.47B.
The highest annual operating cash flow of $21.47B was reported in 2024. The lowest in the available history was $1.38B in 1989.
Merck & Co. Operating Cash Flow by Year
Merck & Co. Operating Cash Flow 2025: $16.47B
2025's operating cash flow for Merck & Co. came in at $16.47B, declined 23.3% below 2024.
Merck & Co. Operating Cash Flow 2024: $21.47B
Merck & Co. posted operating cash flow of $21.47B in 2024, surged 65.1% from 2023. This figure represents the highest annual value in the available history.
Merck & Co. Operating Cash Flow 2023: $13.01B
In 2023, Merck & Co. reported operating cash flow of $13.01B, plunged 31.9% below 2022.
Merck & Co. Operating Cash Flow 2022: $19.09B
Merck & Co. operating cash flow in 2022 was $19.09B, surged 35.3% from 2021.
Merck & Co. Operating Cash Flow 2021: $14.11B
Merck & Co. operating cash flow in 2021 was $14.11B.
See more financial history for Merck & Co. (MRK).
Sector peers by Operating Cash Flow
Healthcare peers of Merck & Co. (MRK), ranked by their latest operating cash flow
| $24.53B | |
| $19.70B | |
| $19.03B | |
| $18.56B | |
| $16.81B | |
| $14.57B | |
| $9.96B | |
| $7.82B |
- $24.53B
- $19.70B
- $19.03B
- $18.56B
- $16.81B
- $14.57B
- $9.96B
Frequently asked questions
Merck & Co. (MRK) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation